InspireMD Inc. (NSPR)
Nasdaq: NSPR · Surgical & Medical Instruments & Apparatus · Miami, FL · filing with the SEC since 2009
Who owns InspireMD Inc.
As filed with the SECHolders of 5% or more
9
Nantahala Capital Management, LLC holds 9.99% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G/A filed May 15, 2026 says.
Directors and officers
12
report now, of 21 people on the record since 2011. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 9 named at left.
Holders of 5% or moreshare of the class, as filed
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · 9.99% in Nov 14, 2025
Marshall Wace, Llp
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.0001 per share
Rosalind Advisors, Inc.
SCHEDULE 13G/A · filed Feb 11, 2026 · Common Shares · 9.9% in Aug 11, 2025
Michael A. Lawless
SCHEDULE 13D · filed Oct 29, 2025 · Common Stock, $0.0001 par value per share
Aberdeen Group plc
SCHEDULE 13G/A · filed Feb 2, 2026 · Common Stock, $0.0001 par value per share · 5.95% in Nov 7, 2025
Orbimed Advisors LLC
SCHEDULE 13G · filed Feb 17, 2026 · Common Stock, par value $0.0001 per share · 4.1% in Nov 14, 2025
Parkman Healthcare Partners LLC
SCHEDULE 13G · filed Nov 14, 2025 · Common Stock, $0.0001 par value
Nantahala Capital Partners Limited Partnership
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.0001 per share
Marvin Slosman
SCHEDULE 13D · filed Apr 24, 2026 · Common Stock, $0.0001 par value per share
Velan Capital Master Fund LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.1% in Aug 6, 2025
Craig Shore
SCHEDULE 13D/A · filed Oct 29, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
What NSPR reports owning in othersstakes of 5% or more, and other ties
InspireMD Inc. reports no stake in another company in the record.
Insider tradesForm 4
12sales
18purchases
0sales on a scheduled plan
1people selling
$100,000sold, in dollars
$500,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Gleason Shane Thomas | Chief Commercial Officer | 12 | $100,000 | 0 | 0 | $0 |
| Stuka Paul | director | 0 | $0 | 0 | 14 | $300,000 |
| Ward Scott R. | director | 0 | $0 | 0 | 2 | $100,000 |
| Slosman Marvin | CEO and President | 0 | $0 | 0 | 1 | $0 |
| Roubin Gary S | director | 0 | $0 | 0 | 1 | $100,000 |